Medigene Statistics
Medigene (MDG1) Stock Statistics & Valuation Metrics
Total Valuation
Medigene has a market cap or net worth of EUR 50.62K. The enterprise value is EUR 19.15M.
- Market Cap
- EUR 50.62K
- Enterprise Value
- EUR 19.15M
Share Statistics
Medigene has 14,887,594 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 14,887,594
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Medigene’s return on equity (ROE) is -0.77 and return on invested capital (ROIC) is -61.87%.
- Return on Equity (ROE)
- -0.77
- Return on Assets (ROA)
- -0.51
- Return on Invested Capital (ROIC)
- -61.87%
- Return on Capital Employed (ROCE)
- -0.66
- Revenue Per Employee
- 69.36K
- Profits Per Employee
- -185.94K
- Employee Count
- 87
- Asset Turnover
- 0.19
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Medigene is -0.10. Medigene’s PEG ratio is -0.00.
- PE Ratio
- -0.10
- PS Ratio
- 0.33
- PB Ratio
- 0.08
- Price to FCF
- -0.12
- Price to Operating Cash Flow
- -0.11
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Medigene had revenue of 6.03M and earned -16.18M in profits. Earnings per share was -1.25.
- Revenue
- 6.03M
- Gross Profit
- 4.39M
- Operating Income
- -16.15M
- Pretax Income
- -16.59M
- Net Income
- -16.18M
- EBITDA
- -14.58M
- Earnings Per Share (EPS)
- -1.25
Cash Flow
In the last 12 months, operating cash flow was -14.17M and capital expenditures -621,000, giving a free cash flow of -14.79M billion.
- Operating Cash Flow
- -14.17M
- Free Cash Flow
- -14.79M
- Free Cash Flow per Share
- -1.29
Dividends & Yields
Medigene pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -802.20%
- Earnings Yield
- -986.67%
Stock Price Statistics
- Beta
- 1.93
- 52-Week Price Change
- -83.33%
- 50-Day Moving Average
- 0.02
- 200-Day Moving Average
- 0.03
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
Medigene upcoming earnings date is ―, TBA (Not Confirmed).
- Last Earnings Date
- Nov 13, 2025
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Medigene as a current ratio of 2.53, with Debt / Equity ratio of 14.00%
- Current Ratio
- 2.53
- Quick Ratio
- 2.53
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.39
- Interest Coverage Ratio
- -29.47
Taxes
In the past 12 months, Medigene has paid -415.00K in taxes.
- Income Tax
- -415.00K
- Effective Tax Rate
- 0.03
Enterprise Valuation
Medigene EV to EBITDA ratio is 0.24, with an EV/FCF ratio of 0.24.
- EV to Sales
- -0.62
- EV to EBITDA
- 0.24
- EV to Free Cash Flow
- 0.24
- EV to Operating Cash Flow
- 0.25
Balance Sheet
Medigene has EUR 14.02M in cash and marketable securities with EUR 2.54M in debt, giving a net cash position of EUR 11.48M billion.
- Cash & Marketable Securities
- EUR 14.02M
- Total Debt
- EUR 2.54M
- Net Cash
- EUR 11.48M
- Net Cash Per Share
- EUR 0.77
- Tangible Book Value Per Share
- EUR 1.45
Margins
Gross margin is 72.77%, with operating margin of -267.63%, and net profit margin of -268.10%.
- Gross Margin
- 72.77%
- Operating Margin
- -267.63%
- Pretax Margin
- -274.98%
- Net Profit Margin
- -268.10%
- EBITDA Margin
- -255.97%
- EBIT Margin
- -265.96%
Scores
- Smart Score
- 5
- AI Score
- ―
